This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Technetium-99m (Tc-99m) methyl diphosphonate (MDP) bonescans are a potentially viable noninvasive option for diagnosing calciphylaxis, according to a team at the University of Massachusetts in Worcester, MA. The team assessed the potential diagnostic utility of bonescans in calciphylaxis based on a review of the literature.
The new horizons of advanced imaging, especially in oncology, must increasingly consider not only diagnostic efficacy but also sustainability for patients, prize-winning researchers told ECR 2025 delegates. Whole-body MRI is emerging as a superior tool for assessing bone marrow and monitoring therapy response in advanced breast cancer.
Prostate-specific membrane antigen (PSMA) PET imaging could improve the length and quality of life for patients with recurrent prostate cancer, according to a study published October 23 in JAMA Network Open. population and was informed by data from real-world settings.
SPECT/CT imaging can help manage patients undergoing radiopharmaceutical therapy (RPT) with Pluvicto for advanced prostate cancer, according to a study published August 8 in the Journal of Nuclear Medicine. Yet whether SPECT/CT can be used to determine disease progression or response has yet to be delineated, they noted.
Moreover, the approach could help detect disease that other effective prostate cancer PET radiotracers may miss, said Heying Duan, MD, a nuclear medicine research scientist at Stanford University, during a November 26 scientific session. Image courtesy of Heying Duan, MD, Stanford University.
PET/CT imaging with a new radiotracer (F-18 PSMA-1007) is superior to MRI prior to surgery in men with intermediate-risk and high-risk prostate cancer, according to a study published on July 1 in JAMA Oncology. Out of 150 men who participated, 134 ultimately underwent radical prostatectomies (the mean age was 62 years old).
Theranostics is increasingly being used to image and treat prostate cancer and neuroendocrine tumors. Several presenters at the Society for Nuclear Medicine and Molecular Imaging's (SNMMI) 2024 meeting in Toronto shared new findings in women's studies. Women's theranostics appears to already be on the horizon.
Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. It certainly doesn't help matters that the disease has been linked to gadolinium-based contrast agents, a ubiquitous tool in the MR armamentarium. How are imaging experts and others handling NSF?
PET/CT imaging with a new gallium-68-based prostate cancer radiotracer shows promise for detecting recurrent metastatic disease, according to a study published February 20 in the Journal of Nuclear Medicine. Imaging agents with low uptake in at-risk organs and higher tumor uptake are needed, they noted.
An article in the Journal of Nuclear Medicine reports findings of a multi-center retrospective study that compares bonescan with PSMA PET for initial staging of prostate cancer.
While broken bones are common injuries experienced across all ages, older individuals are at higher risk. Bones become more fragile and porous with age, so less force is needed to break their structure. Medical imaging is used to help diagnose these injuries, so doctors can propose appropriate treatment plans.
As I was on the phone with a colleague trying to convince the referrer of why I think a patient has Paget’s disease instead of metastases, I described the cortical thickening of the iliopectineal line and the lack of activity on the bonescan at the site and elsewhere throughout the body. And allow me to tell you why.
mtaschetta-millane Tue, 07/02/2024 - 09:53 July 2, 2024 — A new editorial paper was published in Oncoscience ( Volume 11 ) on May 20, 2024, entitled, “ Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiation therapy in prostate cancer.” In this new editorial, researchers Richard L.J.
MRI is key to diagnosis, obtain this imaging in all patients who raise clinical suspicion Patients with hemodynamic instability and neurologic compromise warrant empiric antibiotics. The degree of elevation does not predict disease severity. Baseline labs should not guide diagnosis, but may assist in later management.
Doctors use imaging tests to see inside a patient’s body and diagnose their illnesses and injuries. There are many different types of imaging tests, each with their own method of generating a photo of the inside of the human body. A doctor will often use a diagnostic imaging test to check patients for signs of cancer.
Nuclear scans produce images of the body’s anatomy that cannot be obtained as clearly or fully with other imaging techniques. Nuclear medicine tests use a very small amount of radioactive tracer (radionuclide or radioisotope) which is specific for the organ or tissue to be scanned. We look forward to serving you.
Bonescan shows diffuse uptake in the markedly enlarged right breast secondary to increased blood pool activity and impaired washout. Bonescan showed diffuse uptake in the markedly enlarged right breast secondary to increased blood pool activity and impaired washout. Imaging in inflammatory breast carcinoma.
Osteoporosis Osteoporosis is a disorder which affects the bones and is characterized by a progressive loss of bone tissue. This weakens bones making them porous, fragile, and susceptible to fractures. Osteoporosis is a common bonedisease with as many as 1.5
Prostate-specific membrane antigen (PSMA)-PET/CT bests conventional imaging when it comes to identifying high-risk, nonmetastatic, hormone-sensitive prostate cancer, researchers have reported. The results were published January 3 in JAMA Network Open. "[Our
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content